The Clinical Research Progress and in vivo Poison Reduction of <sup>223</sup>RaCl<sub>2</sub> in Treating Bone Metastases of Castration-resistant Prostate Cancer

The Clinical Research Progress and in vivo Poison Reduction of ²²³RaCl₂ in Treating Bone Metastases of Castration-resistant Prostate Cancer

XUE Shuai, LI Danni, BAI Qingyun, LI Xiao

PDF(1054 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1054 KB)

Labeled Immunoassays and Clinical Medicine ›› 2023, Vol. 30 ›› Issue (5) : 876-880. DOI: 10.11748/bjmy.issn.1006-1703.2023.05.029

Review

The Clinical Research Progress and in vivo Poison Reduction of ²²³RaCl₂ in Treating Bone Metastases of Castration-resistant Prostate Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 30(5): 876-880 https://doi.org/10.11748/bjmy.issn.1006-1703.2023.05.029

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1054 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉